Font Size:
a
A
A
Keyword [drug design]
Result: 161 - 180 | Page: 9 of 10
161.
Design, Synthesis And Antitumor Activity Evaluation Of Plk1 Inhibitors
162.
Computer-aided Rapid Identification And Biological Evaluation Of Bioactive Lead Compounds
163.
Structure-based FGF21 Drug Design And Ligand-Receptor Interaction
164.
Applications Of Three-Dimensional Biologically Relevant Spectrum In Computer-Aided Drug Design
165.
Using Ligand Similarity Profile For Drug Design
166.
Quantum Chemistry Calculations Of Halogen Bonding,Guanidinium-Arginine Interactions And Transition State Of Drug Synthetic Reactions In Drug Design
167.
The Drug Design And Mechanism Study On Lipid Kinase PI4K?? And Protein Kinase PDK1
168.
Design,Dynthesis,Activity And Mechanism Studies Of Dual Inhibitors Of ?-glucosidase And PTP1B
169.
Design,Synthesis And Evaluation Of Novel A
2A
Inhibitors And Novel Hedgehog/PI3K Dual Inhibitors
170.
Detection Of HDACs Ihibitors Through Computer Aided Drug Design
171.
The Development Of Network-based Methods For Drug Design And Their Applications In Anticancer Drug Discovery
172.
Design, Synthesis And Activity Assay Of 1-benzyl- Tetrahydroisoquinoline Derivatives
173.
Design,Synthesis And Anti-Diabetic Activity Evaluation Of Thiazolidinediones Based On Molecular Fragments
174.
Rational Drug Design Of Three GPCRs Related To Neurodegenerative Diseases
175.
A Preliminary Study On Virtual Screening And Anti-hepatoma Activity Of New Type SIRT1 Inhibitors
176.
Design,Synthesis And Activity Studies Of Multi-Target Anti-Diabetic Lead Compounds
177.
Design And Synthesis Of Novel Anti-Diabetic Lead Compounds
178.
Design And Synthesis Of 4-thiazolidinone As PTP1B Inhibitors
179.
Drug Design And The Mechanism Of ?-Ketoacyl–Acyl Carrier Protein Synthase ?(FabH)Inhibitors
180.
Molecular Modeling And Drug Design Based On HIV-1 Related Proteins
<<First
<Prev
Next>
Last>>
Jump to
